Yi Sang 4
4 · ZIMMER BIOMET HOLDINGS, INC. · Filed Feb 19, 2025
Insider Transaction Report
Form 4
Yi Sang
Group President, Asia Pacific
Transactions
- Exercise/Conversion
Common Stock
2025-02-18+11,138→ 16,676 total - Award
Restricted Stock Units
2025-02-14+11,138→ 11,138 totalFrom: 2025-02-18Exp: 2025-02-18→ Common Stock (11,138 underlying) - Exercise/Conversion
Restricted Stock Units
2025-02-18−11,138→ 0 totalFrom: 2025-02-18Exp: 2025-02-18→ Common Stock (11,138 underlying)
Footnotes (3)
- [F1]Includes 216 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through February 18, 2025.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Zimmer Biomet Holdings, Inc. (the "Company").
- [F3]On February 18, 2022, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022 - 2024. As determined on February 14, 2025, based on actual performance, the reporting person earned 11,138 RSUs, which vested on February 18, 2025